Last reviewed: June 24, 2026
Last updated: June 24, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Wegovy (semaglutide) is a GLP-1 receptor agonist that helps regulate hunger and blood sugar through a careful dose-escalation protocol. Most patients begin at 0.25 mg weekly and progress over 16 weeks toward a target dose of 2.4 mg, a schedule designed by Novo Nordisk based on clinical trial data showing optimal weight loss and tolerability. Understanding this dosing framework helps you make informed decisions about your treatment journey.
Understanding the Standard Wegovy Titration Schedule
Wegovy's official dosing protocol spans four months and divides into five dose levels. Patients inject 0.25 mg in weeks 1–4, then increase to 0.5 mg for weeks 5–8. Weeks 9–12 call for 1.0 mg weekly, followed by 1.7 mg for weeks 13–16, and finally 2.4 mg as the maintenance dose. This gradual climb allows your body to adapt to the medication's effects on appetite and digestion.
The rationale behind slow titration is safety and tolerability. Clinical trials showed that rapid dose increases triggered nausea, vomiting, and gastrointestinal discomfort in a larger subset of patients. By spacing increases 4 weeks apart, your system develops tolerance to side effects, and many people report them diminishing by the second or third dose level. Your doctor may recommend staying at an intermediate dose if 2.4 mg causes persistent symptoms.
Why Some Patients Pause or Extend Dosing Intervals
Not everyone advances through the standard schedule on time. If you experience significant nausea, vomiting, constipation, or loss of appetite that interferes with nutrition, your prescriber may recommend staying at your current dose for an extra 4 weeks or longer. This flexibility is supported by real-world clinical experience and allows your tolerance to build naturally. Rushing through doses to reach 2.4 mg quickly often backfires, leading to treatment discontinuation due to intolerable side effects.
Some patients find that doses below 2.4 mg deliver their target weight loss without escalation. A 0.5 mg or 1.0 mg weekly dose may produce 10–15% body weight reduction over 6 months in individuals with strong GLP-1 receptor sensitivity. Your genetic makeup, metabolic rate, and baseline weight influence how responsive you are at each dose level. PlexusDx's Precision Peptide Genetic Test analyzes your GLP1R rs6923761 variant and 48 other peptide-pathway markers to predict your likelihood of success at different dose tiers.
Managing Side Effects During Dose Increases
Nausea peaks in the first 3–5 days after a dose increase and typically fades within a week. During this adjustment window, eat smaller, frequent meals with easily digestible foods like broths, crackers, and lean proteins. Stay hydrated, avoid fatty or overly sweet foods, and take anti-nausea medication only if approved by your prescriber. Most patients report that ginger tea, peppermint, or gentle walking aids comfort during this period.
Constipation is another common complaint on semaglutide because the medication slows gastric emptying. Increase fiber intake gradually—sudden high-fiber diets can worsen bloating—and drink at least 8–10 glasses of water daily. If constipation persists beyond 3 weeks at a new dose, discuss osmotic laxatives or stool softeners with your doctor. Skipping meals or undereating worsens constipation; maintain adequate calorie and nutrient intake even as appetite naturally declines.
How Compounded Semaglutide Offers Dosing Flexibility at Lower Cost
PlexusDx sources compounded semaglutide from licensed 503A compounding pharmacies, ensuring quality and purity equivalent to brand-name Wegovy but at a fraction of the cost. Compounded formulations start at $149 per month and remain at that flat price across all dose levels—your dose may need to go up, but your price won't. This eliminates the financial barrier many patients face when advancing toward higher maintenance doses, making long-term treatment sustainable.
Compounded semaglutide injections come with PlexusDx's dosing guidance protocol, developed by clinical specialists who review your medical history, weight loss progress, and symptom tolerance every 4 weeks. Unlike retail Wegovy refills that occur automatically, PlexusDx adjusts your prescription timing based on your actual response and tolerability. PlexusDx serves all 50 states, accepts HSA and FSA funds, and requires no insurance or membership fees, making personalized GLP-1 therapy accessible regardless of coverage status.
Genetic Insights Into Your Dose Response and Weight Loss Potential
Your response to semaglutide at any dose level is partly determined by inherited genetic variants in appetite-control and energy-metabolism pathways. The FTO rs9939609 variant, for example, is associated with higher baseline appetite drive; carriers may require higher semaglutide doses to achieve the same appetite suppression as non-carriers. The GIPR rs1800437 and MC4R rs17782313 variants also influence how effectively GLP-1 medications control hunger and promote weight loss.
PlexusDx's Precision Peptide Genetic Test identifies 14 peptide-pathway maps and 150+ genetic insights tied to your weight loss biology. After one month of treatment, this $99 add-on test guides your dosing strategy by revealing which GLP-1 approach—semaglutide, tirzepatide, or combination therapy—aligns with your genetic profile. Patients with certain variant combinations often respond exceptionally well to microdose protocols or benefit from earlier escalation to dual-compound options, enabling faster, safer weight loss without unnecessary side effects.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What happens if I need to skip a weekly Wegovy injection or delay my dose increase?
If you miss one weekly dose, inject as soon as you remember, then resume your regular schedule the following week. Delaying a dose increase by 1–2 weeks is medically safe and often helpful if side effects are severe. Contact your PlexusDx care team before skipping doses; they can adjust your prescription timeline to match your tolerance and help you stay on track toward your weight loss goal.
How much weight loss should I expect at each dose level of semaglutide?
Pivotal trials showed average weight loss of 4% at 0.5 mg, 8% at 1.0 mg, and 13–15% at 2.4 mg over 68 weeks. However, individual results vary widely based on diet, exercise, genetics, and underlying metabolic health. Some patients plateau at intermediate doses (1.0–1.7 mg) and achieve their goal without advancing further, while others need the full 2.4 mg to reach meaningful loss.
Can I stay on a low Wegovy dose indefinitely, or do I need to eventually reach 2.4 mg?
You can remain on any dose that produces your desired weight loss without intolerable side effects. Many patients stabilize at 0.5–1.0 mg and maintain it long-term. The 2.4 mg target is a maximum recommendation, not a requirement; your prescriber's goal is sustainable weight loss at the lowest effective dose for you personally.
Is compounded semaglutide as effective as brand-name Wegovy?
Compounded semaglutide from licensed 503A pharmacies contains the identical active ingredient and follows strict quality standards. Clinical effectiveness is equivalent to brand Wegovy; the difference is cost and access. PlexusDx's compounded semaglutide ($149/month) offers the same GLP-1 mechanism at a lower price point with personalized dosing oversight.
How does the Precision Peptide Genetic Test help guide my semaglutide dosing?
The test identifies variants in your GLP1R, GIPR, FTO, and MC4R genes that predict dose sensitivity and weight loss responsiveness. Results guide PlexusDx clinicians to recommend optimal starting doses, expected dose escalation speed, and whether dual-compound therapy (combining semaglutide and tirzepatide) might accelerate your progress. This personalization reduces trial-and-error and improves side effect tolerability.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What If I Skip a Dose of Ozempic? Your Guide to Staying on Track
What Are the Side Effects When You Stop Taking Ozempic?